-
2024-514248-95-00
Uncontrolled Asthma 5
-
2025-524697-42-00
Pleural infections 5
-
2024-514701-57-01
non Small Cell Lung Cancer 4
-
2024-518785-28-00
Cystic Fibrosis 6
-
2024-511420-13-00
Community-acquired pneumonia 4
-
2025-522288-13-00
Patients with pretreated extensive-stage small cell lun 4
-
2023-510440-20-00
Fibrotic interstitial lung disease 11
-
2025-521709-42-00
Allergic rhinoconjunctivitis with or without asthma due 5
-
2025-522964-33-00
Alpha1-proteinase inhibitor deficiency 6
-
2025-524819-37-00
obstructive sleep apnea 6
-
2024-518821-13-00
Non-cystic Fibrosis Bronchiectasis 4
-
2025-524821-42-00
COPD 6
-
2025-522974-35-00
Respiratory disease.
Prescripcion o indicación de gasom 6
-
2025-521736-10-00
Allergic rhinoconjunctivitis with or without controlled 5
-
2024-519391-11-00
Respiratory viral disease 3
-
2025-522983-33-00
Chronic rhinosinusitis with nasal polyps 5
-
2025-522376-82-00
allergic diseases (allergic rhinosinusitis, allergic as 5
-
2025-523033-26-00
Patients with EGFR-mutated metastatic NSCLC, without CN 4
-
2024-516085-11-00
Chronic Obstructive Pulmonary Disease 9
-
2025-521770-34-00
Chronic pulmonary aspergillosis 3
-
2024-516097-30-00
Community acquired pneumonia (CAP) 6
-
2025-521221-32-00
Advanced or Metastatic Non-Small Cell Lung Cancer 5
-
2024-514355-16-01
Acute Respiratory Distress Syndrome (ARDS) 5
-
2024-519465-22-01
planned to be treated in the radiotherapy department of 5